M. Longy

发表

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jaana M. Hartikainen, W. Chung, 2019, Nature Genetics.

Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation.

A. Vincent-Salomon, O. Delattre, M. Bollet, 2012, Cancer research.

A refined molecular taxonomy of breast cancer

F. Bertucci, D. Birnbaum, P. Finetti, 2011, Oncogene.

Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer.

D. Birnbaum, A. Vincent-Salomon, D. Stoppa-Lyonnet, 1996, Cancer research.

Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations

I. de Mascarel, G. MacGrogan, R. Iggo, 2010, Breast Cancer Research.

BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations.

J. Simard, D. Yannoukakos, J. Peyrat, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

BRCA 1 Wild-Type Allele Modifies Risk of Ovarian Cancer in Carriers of BRCA 1 GermLine Mutations 1

J. Simard, D. Yannoukakos, J. Peyrat, 2003 .

No evidence for germline PTEN mutations in families with breast and brain tumours

C. Lefebvre, P. Laurent-Puig, C. Eng, 1999, International journal of cancer.

Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype.

C. Eng, V. Coulon, B. Duboué, 1998, Journal of medical genetics.

Familial cluster of ovarian small cell carcinoma: a new mendelian entity?

M. Longy, M. Trojani, C. Toulouse, 1996, Journal of medical genetics.

Mutations at BRCA1: the medullary breast carcinoma revisited.

D. Birnbaum, J. Peyrat, D. Stoppa-Lyonnet, 1998, Cancer research.

Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing

M. Bihoreau, N. Servant, D. Stoppa-Lyonnet, 2018, International journal of cancer.

Pharmacogenetics of human carboxylesterase 2, an enzyme involved in the activation of irinotecan into SN‐38

J. Robert, M. Longy, Delphine Meynard, 2004, Clinical pharmacology and therapeutics.

Breast tumors: an overview

D. Birnbaum, C. Theillet, H. Sobol, 2011 .

Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations.

K. Hoang-Xuan, G. Thomas, M. Sanson, 1999, International journal of cancer.

Thyroid pathologic findings in patients with Cowden disease.

I. Soubeyran, D. Bonneau, M. Longy, 1999, Annals of diagnostic pathology.

CDKN2A–CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma

P. Dubus, T. Jouary, Y. Idrissi, 2010, Modern Pathology.

FGFRI and PLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers

P. Sismondi, D. Birnbaum, C. Theillet, 1993, Genes, chromosomes & cancer.

Proteus syndrome: Report of a case with AKT1 mutation in a dental cyst.

C. Cancés, E. Bieth, M. Longy, 2015, European journal of medical genetics.

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Annette Lee, W. Chung, R. Nussbaum, 2018, Human mutation.

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

W. Chung, J. Benítez, R. Eeles, 2020, Breast Cancer Research.

Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families

K. Dahan, D. Stoppa-Lyonnet, B. Gilbert-Dussardier, 2017, Carcinogenesis.

Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity

F. Chibon, L. Faivre, Pierre Vabres, 2007, European Journal of Human Genetics.

Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

D. Altshuler, P. Fasching, P. Hall, 2013, PLoS genetics.

Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome.

N. Philip, N. Girard, H. Sobol, 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

PTEN (phosphatase and tensin homolog deleted on chromosome ten)

M. Longy, 2011 .

Cowden disease. Report of a family and review.

D. Lacombe, M. Longy, 1996, Annales de genetique.

Alterations of p53 and PIK3CA/AKT/mTOR Pathways in Angiosarcomas: A Pattern Distinct from Other Sarcomas with Complex Genomics

C. Antonescu, A. Italiano, R. Maki, 2012 .

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

M. Daly, D. Altshuler, F. Couch, 2010, PLoS Genetics.

BRCA2 mutations in hereditary breast and ovarian cancer in France.

R. Lidereau, G. Lenoir, S. Mazoyer, 1997, American journal of human genetics.

The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.

J. Trent, H. Cunliffe, A. Berchuck, 2016, Gynecologic oncology.

Mutations at BRCAJ: The Medullary Breast Carcinoma Revisited1

D. Birnbaum, J. Peyrat, D. Stoppa-Lyonnet, 2015 .

The common fragile site FRA16C does not map within the 16q smallest region of overlap number 2 frequently lost in breast carcinoma.

P. Rocca-Serra, L. Taine, M. Longy, 2003, Cancer genetics and cytogenetics.

Cowden's syndrome: possible association with testicular seminoma

J. Mazereeuw-Hautier, M. Longy, J. Bonafé, 2004, The British journal of dermatology.

Mutational analysis of the PTEN gene in gliomas: Molecular and pathological correlations

K. Hoang-Xuan, G. Thomas, M. Sanson, 1999 .

A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

F. Révillion, Chloé-Agathe Azencott, N. Sevenet, 2020, BMC Medical Research Methodology.

Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions

D. Birnbaum, C. Eng, C. Theillet, 1997, Oncogene.

Chromosomal analysis of colonic adenomatous polyps.

P. Couzigou, M. Longy, R. Saura, 1990, Cancer genetics and cytogenetics.

Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.

T. Jouary, J. Merlio, M. Beylot-Barry, 2010, The Journal of investigative dermatology.

Value of microsatellite instability typing in detecting hereditary non-polyposis colorectal cancer. A prospective multicentric study by the Association Aquitaine Gastro.

V. Picot, T. Frebourg, F. Paraf, 2005, Gastroenterologie clinique et biologique.

Method for the Purification of Tissue DNA Suitable for PCR After Fixation with Bouin's Fluid: Uses and Limitations in Microsatellite Typing

B. Duboué, P. Soubeyran, M. Longy, 1997, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics

J. Fricker, L. Faivre, A. Bouhnik, 2010, Genetics in Medicine.

Endoscopic Phenotype of Monoallelic Carriers of MUTYH Gene Mutations in the Family of Polyposis Patients: A Prospective Study

J. Saurin, J. Fricker, L. Faivre, 2019, Diseases of the colon and rectum.

Spectrum of PTCH1 mutations in French patients with Gorlin syndrome.

V. Drouin‐Garraud, D. Lacombe, Y. Bignon, 2003, The Journal of investigative dermatology.

[Li-Fraumeni syndrome: update, new data and guidelines for clinical management].

O. Delattre, D. Frappaz, C. Bonaiti-Pellié, 2001, Bulletin du cancer.

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

E. Schröck, C. Lázaro, G. Capellá, 2020, European Journal of Human Genetics.

Ovarian Clear Cell Carcinoma in Cowden Syndrome.

G. MacGrogan, P. Pujol, J. Tinat, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Impaired social cognition and fine dexterity in patients with Cowden syndrome associated with germline PTEN variants

B. Garcin, B. Degos, M. Longy, 2022 .

Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers.

J. Simard, D. Yannoukakos, J. Peyrat, 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Common BRCA 2 Variants and Modification of Breast and Ovarian Cancer Risk in BRCA 1 Mutation Carriers

J. Simard, D. Yannoukakos, J. Peyrat, 2005 .

Novel PTEN germline mutation in a family with mild phenotype: difficulties in genetic counseling.

N. Philip, B. Chabrol, M. Longy, 2013, Gene.

Association between Cowden syndrome and Lhermitte-Duclos disease: report of two cases and review of the literature.

A. Laquérriere, S. Derrey, F. Proust, 2004, Surgical neurology.

Polymerase Chain Reaction Diagnosis of t(14;18) From Paraffin‐Embedded Tissues Fixed With Holland Bouin Fluid

I. Soubeyran, I. Hostein, M. Longy, 1998, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Gingival Biopsy to Detect Mosaicism in Overgrowth Syndromes: Report of Two Cases of Megalencephaly-Capillary Malformation Syndrome with Periodontal Anomalies

E. Bieth, M. Longy, I. Bailleul-Forestier, 2020, Case reports in dentistry.

Localization of the gene for Cowden disease to chromosome 10q22–23

E. Mariman, D. Easton, R. Eeles, 1996, Nature Genetics.

MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non‐polyposis colorectal cancer in young patients

B. Petit, F. Paraf, M. Longy, 2001, Histopathology.

Direct chromosome analysis in the second and third trimesters by placental biopsy in 30 pregnancies

M. Longy, R. Saura, J. Horovitz, 1989, British journal of obstetrics and gynaecology.

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

A. Whittemore, L. Kiemeney, S. Cross, 2016, Nature Communications.

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

R. Nussbaum, D. Steinemann, V. Pankratz, 2014, Breast Cancer Research.

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Mads Thomassen, Stephen Fox, Dieter Niederacher, 2011, Breast Cancer Research.

SMARCA4 (BRG1) Loss of Expression Is a Useful Marker for the Diagnosis of Ovarian Small Cell Carcinoma of the Hypercalcemic Type (Ovarian Rhabdoid Tumor): A Comprehensive Analysis of 116 Rare Gynecologic Tumors, 9 Soft Tissue Tumors, and 9 Melanomas

F. Guyon, J. Coindre, G. MacGrogan, 2015, The American journal of surgical pathology.

PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas.

V. Brouste, G. MacGrogan, N. Sevenet, 2022, Cancer genetics.

Inherited PTEN mutations and the prediction of phenotype.

N. Leslie, M. Longy, 2016, Seminars in cell & developmental biology.

Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas

C. Antonescu, J. Coindre, A. Italiano, 2012, Cancer.

Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

F. Révillion, R. Lidereau, N. Sevenet, 2021, American journal of human genetics.

High allele loss rates at I7q I2‐q2I in breast and ovarian tumors from BRCAI‐linked families

J. Chang-Claude, B. Ponder, C. Larsson, 1995 .

High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome

V. Brouste, N. Sevenet, B. Gilbert-Dussardier, 2013, Journal of Medical Genetics.

Contribution of PTEN large rearrangements in Cowden disease: a multiplex amplifiable probe hybridisation (MAPH) screening approach

F. Chibon, L. Mauriac, J. Bressieux, 2008, Journal of Medical Genetics.

Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas.

C. Larsson, H. Kremer, C. Eng, 1997, Cancer research.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2019, Nature Genetics.

Impact of chromosomal instability on colorectal cancer progression and outcome

I. Soubeyran, C. Bascoul-Mollevi, C. Theillet, 2014, BMC Cancer.

Genetic alterations in colorectal cancer, comparative analysis of deletion events, and point mutations.

C. Ged, H. de Verneuil, H. Verneuil, 1998, Cancer genetics and cytogenetics.

Insertion of Alu elements at a PTEN hotspot in Cowden syndrome

P. Couzigou, N. Sevenet, E. Barouk-Simonet, 2017, European Journal of Human Genetics.

Comprehensive analysis of PTEN status in breast carcinomas

V. Brouste, G. MacGrogan, N. Sevenet, 2013, International journal of cancer.

Chromosome analysis of adenomatous polyps of the colon: possible existence of two differently evolving cytogenetic groups.

P. Couzigou, L. Taine, F. Dumas, 1993, Cancer genetics and cytogenetics.

Allelic imbalance, including deletion of PTEN/MMAC1, at the Cowden disease locus on 10q22‐23, in hamartomas from patients with cowden syndrome and germline PTEN mutation

R. Eeles, A. Goldstein, C. Eng, 1998, Genes, chromosomes & cancer.

Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study

E. Letouzé, G. MacGrogan, N. Sevenet, 2017, Genes, chromosomes & cancer.

Mutation analysis of PALB2 gene in French breast cancer families

D. Stoppa-Lyonnet, O. Sinilnikova, S. Mazoyer, 2015, Breast Cancer Research and Treatment.

Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

M. Daly, D. Altshuler, F. Couch, 2010, PLoS genetics.

Mutations of the human PTEN gene

D. Bonneau, M. Longy, 2000, Human mutation.

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

Laetitia Huiart, Dominique Leroux, Bernard Bonaïti, 2011, JAMA.

High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1.

P. Rocca-Serra, H. Prydz, L. Taine, 2000, Genomics.

Integrated Systems and Technologies Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA 1 / 2 Inactivation

O. Delattre, M. Bollet, C. Houdayer, 2012 .

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity

A. Vincent-Salomon, O. Delattre, C. Lucchesi, 2007, Breast Cancer Research.

Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation

D. Stoppa-Lyonnet, S. Mazoyer, F. Damiola, 2021, Breast cancer research : BCR.

Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.

C. Bonaïti‐pellié, L. Essioux, O. Sinilnikova, 1998, American journal of medical genetics.

Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers

I. Hostein, M. Longy, F. Dorion-Bonnet, 1995, Genes, chromosomes & cancer.

WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type

D. Birnbaum, F. Penault-Llorca, V. Bardou, 2001, Oncogene.

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

R. Eeles, J. Hopper, D. Easton, 2021, American journal of obstetrics and gynecology.

Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients

B. Bui, J. Coindre, C. Bonaïti‐pellié, 2006, International journal of cancer.

Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.

C. Larsson, C. Eng, R. Parsons, 1997, Cancer research.

Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas.

D. Birnbaum, H. Sobol, J. Jacquemier, 1997, Cancer research.

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

R. Siebert, A. Berchuck, H. Mackay, 2014, Nature Genetics.

An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis

V. Brouste, I. de Mascarel, G. MacGrogan, 2012, BMC Medical Genomics.

Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma

H. Feilotter, L. Mulligan, C. Eng, 1999, British Journal of Cancer.

Genome‐wide search for loss of heterozygosity in Burkitt lymphoma cell lines

D. Birnbaum, G. Lenoir, H. Sobol, 2002, Genes, chromosomes & cancer.

PTEN/MMAC1/TEP1 involvement in primary prostate cancers

O. Cussenot, C. Eng, R. Lidereau, 1998, Oncogene.

Unclassified variants identified in BRCA1 exon 11: Consequences on splicing

Olga Anczuków, R. Lidereau, O. Sinilnikova, 2008, Genes, chromosomes & cancer.

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2021, Nature Communications.

Human Adipose‐Derived Stem Cells Expanded Under Ambient Oxygen Concentration Accumulate Oxidative DNA Lesions and Experience Procarcinogenic DNA Replication Stress

Claire Hoede, L. Sensébé, M. Longy, 2016, Stem cells translational medicine.

Myxoma of the mitral valve diagnosed by echocardiography.

P. Gosse, M. Longy, E. Baudet, 1986, American heart journal.

Abnormal phenotype in a child with a "balanced" translocation 8/12 in mosaic state.

M. Longy, R. Saura, M. Froute, 1987, American journal of medical genetics.

Increased incidence of pathogenic variants in ATM in the context of testing for breast and ovarian cancer predisposition

N. Sevenet, J. Tinat, L. Venat-Bouvet, 2022, Journal of Human Genetics.

TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing

J. Lemonnier, N. Sevenet, D. Stoppa-Lyonnet, 2021, Cancers.

The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

W. Chung, F. Couch, O. Olopade, 2021, Genetics in Medicine.

Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome

L. Guerrini-Rousseau, N. Sevenet, T. Frebourg, 2017, Journal of Medical Genetics.

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)

R. Lidereau, D. Stoppa-Lyonnet, P. Pujol, 2012, Breast Cancer Research.

Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

Joshua M. Korn, Debra, M. Daly, 2010, PLoS genetics.

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Mads Thomassen, Nina Ditsch, Dieter Niederacher, 2009, Human molecular genetics.

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1/2 carrier cohort (GENEPSO).

R. Lidereau, D. Stoppa-Lyonnet, P. Pujol, 2018 .

GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers

D. Stoppa-Lyonnet, S. Mazoyer, C. Houdayer, 2018, Front. Oncol..

GENESIS: a French national resource to study the missing heritability of breast cancer

D. Stoppa-Lyonnet, O. Sinilnikova, S. Mazoyer, 2016, BMC Cancer.

Title Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA 1 and BRCA 2 mutation carriers

R. Nussbaum, D. Steinemann, V. Pankratz, 2015 .

Pulmonary giant chondromatous hamartoma with multifocal evolution in an infant

N. André, E. Bosdure, P. Petit, 2019, Pediatric blood & cancer.

Brain Magnetic Resonance Imaging in Patients With Cowden Syndrome

C. Gondry-Jouet, B. Dréno, M. Richard, 2005, Medicine.

[African human trypanosomiasis. Unusual discovery owing to recurrent acute pneumopathy].

M. Longy, P. Roussy, M. Delmas, 1979, La Nouvelle presse medicale.

Spectrum of CREBBP gene dosage anomalies in Rubinstein–Taybi Syndrome patients

D. Lacombe, D. Simon, B. Arveiler, 2007, European Journal of Human Genetics.

Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study.

Katherine M. Tucker, Aung Ko Win, Swati G. Patel, 2021, The Lancet. Oncology.

Histoprognostic Grade in Hereditary Breast Cancer: Is Inheritance Linked to BRCA1 a Bad Prognostic Factor?

D. Birnbaum, D. Stoppa-Lyonnet, H. Sobol, 1996 .

A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases.

B. Bui, J. Coindre, C. T. de Lara, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene

V. Gaborieau, D. Yannoukakos, J. Peyrat, 2005, International journal of cancer.

Cowden syndrome with proteus-like manifestations. Recurrence of secondary alterations as PTEN allelic defect in lesional skin. 1 1 Disclosure not available at press time.

L. Laroche, M. Longy, O. Fain, 2004 .

No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study

F. Couch, I. Ellis, T. Rebbeck, 2009, Breast Cancer Research and Treatment.

Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8.

L. Essioux, R. Lidereau, M. Pébusque, 1995, Oncogene.

Risks of transabdominal chorionic villus sampling before the 12th week of amenorrhea

L. Taine, M. Longy, R. Saura, 1990, Prenatal diagnosis.

Timing of transabdominal chorionic villus sampling

M. Longy, R. Saura, J. Horovitz, 1990, The Lancet.

A simple method of chromosomal analysis for malignant solid tumors.

L. Taine, M. Longy, R. Saura, 1992, Cancer genetics and cytogenetics.

A study comparing transcervical with transabdominal chorionic villus sampling (CVS)

M. Longy, R. Saura, J. Horovitz, 1989, British journal of obstetrics and gynaecology.

Feasibility of placental biopsy in the second trimester for fetal diagnosis.

M. Longy, R. Saura, J. Horovitz, 1990, American journal of obstetrics and gynecology.

[Placentocentesis, a new technic in the prenatal diagnosis of chromosome aberrations in the 3d trimester. A preliminary study apropos of 5 cases].

M. Longy, R. Saura, J. Leng, 1988, Journal de gynecologie, obstetrique et biologie de la reproduction.

Novel analytical methods to interpret large sequencing data from small sample sizes

B. Turcq, F. Mahon, A. Groppi, 2019, Human Genomics.

A simple method of chromosomal analysis for colonic adenomatous polyps.

P. Couzigou, M. Longy, R. Saura, 1989, Cancer genetics and cytogenetics.

Acute promyelocytic leukemia with (15;17) translocation and chromosome no. 11 deletion (q23).

M. Longy, M. Boisseau, P. Bernard, 1982, Leukemia research.

1 Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer

F. Bertucci, D. Birnbaum, P. Finetti, 2017 .

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer

F. Bertucci, D. Birnbaum, P. Finetti, 2011, Breast Cancer Research and Treatment.

Impaired social cognition and fine dexterity in patients with Cowden syndrome associated with germline PTEN variants

B. Garcin, B. Degos, M. Longy, 2021, Journal of Medical Genetics.

Intra-observer agreement in single and joint double readings of contrast-enhanced breast MRI screening for women with high genetic breast cancer risks

A. Floquet, M. Longy, M. Asad-Syed, 2013 .

[Myxoma of the mitral leaflet. Apropos of a case].

P. Gosse, M. Longy, E. Baudet, 1985, Archives des maladies du coeur et des vaisseaux.

Maladie de Cowden chez un adolescent

D. Bonneau, Pierre Vabres, M. Longy, 2002 .

Detection of 11 germline inactivating TP53 mutations and absence of TP63 andHCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome

O. Delattre, D. Stoppa-Lyonnet, J. Limacher, 2001, Journal of medical genetics.

Feto‐placental discrepancy on direct chromosomal preparation from chorlonic villus sampling of the second trimester

M. Longy, R. Saura, J. Horovitz, 1988, Clinical genetics.

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.

C Eng, K. Lunetta, O. Olopade, 1998, Human molecular genetics.

Molecular basis of the Li–Fraumeni syndrome: an update from the French LFS families

C. Bonaïti‐pellié, D. Stoppa-Lyonnet, A. Chompret, 2008, Journal of Medical Genetics.

Tissue-Specific Progenitor and Stem Cells Human Adipose-Derived Stem Cells Expanded Under Ambient Oxygen Concentration Accumulate Oxidative DNA Lesions and Experience Procarcinogenic DNA Replication Stress

Claire Hoede, L. Sensébé, M. Longy, 2017 .

Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.

R. Lidereau, M. Longy, M. Champème, 1997, Genes, chromosomes & cancer.

[The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].

P. Pujol, C. Lasset, P. Berthet, 2018, Bulletin du cancer.

Primary cutaneous T-cell lymphomas do not show specific NAV3 gene deletion or translocation.

T. Jouary, J. Merlio, M. Marty, 2008, The Journal of investigative dermatology.

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Jane E. Carpenter, W. Chung, M. Beckmann, 2019, npj Breast Cancer.

Identification of gene polymorphisms of human DNA topoisomerase I in the National Cancer Institute panel of human tumour cell lines

J. Robert, M. Longy, V. Le Morvan, 2006, British Journal of Cancer.

Dramatic response to PARP inhibition in a PALB2-mutated breast cancer: moving beyond BRCA.

J. Blay, A. Italiano, N. Sevenet, 2020, Annals of Oncology.

University of Groningen Identification of a BRCA 2-Specific Modifier Locus at 6 p 24 Related to Breast Cancer

D. Altshuler, V. Pankratz, F. Couch, 2017 .

Loss of heterozygosity on chromosome arm 16q in breast cancer metastases

R. Lidereau, M. Longy, K Driouch, 1997, Genes, chromosomes & cancer.

Deletion of Chromosomes 13q and 14q Is a Common Feature of Tumors with BRCA2 Mutations

Gaëtan MacGrogan, Aurélien de Reyniès, E. Letouzé, 2012, PloS one.

Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas

C. Antonescu, J. Coindre, A. Italiano, 2012, Cancer.

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

F. Couch, B. Bonanni, J. Benítez, 2009, Human molecular genetics.

Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

B. Bonanni, O. Olopade, B. Karlan, 2012 .

Ovarian Clear Cell Carcinoma in Cowden Syndrome.

G. MacGrogan, P. Pujol, J. Tinat, 2019, The Journal of the National Comprehensive Cancer Network.